Navigation Links
Drugs said to Reduce HIV Transmission to Baby

Research has shown the drugs zidovudine and nevirapine reduce the mother-to-child transmission of HIV in breastfeeding women in Africa. //The treatment is generally given late in pregnancy and continued until early infancy. Researchers conducted a study to determine if the two drugs given together reduced transmission more than just nevirapine alone when given after the baby is born. Recent research shows a combination drug therapy given to babies soon after childbirth is effective at preventing HIV transmission from mother to child. The therapy was used because the babies' mothers did not know they were HIV positive until the time of delivery.

The study included 1,100 babies of African women in which the mother did not know she was HIV-positive until about two hours before delivery. The babies were randomly given nevirapine alone or the combination therapy. Both drugs were given immediately after birth. The infant's HIV status was determined at birth and six to eight weeks later.

According to the study, 15 percent of the babies given the combination therapy were HIV-positive compared to 21 percent of the babies given nevirapine alone. Of the babies who were HIV-negative at birth, 7.7 percent of the babies given the combination therapy were HIV-positive at the follow up test compared to 12.1 percent of the babies given nevirapine alone.

Researchers conclude the combination therapy could be a way to reach babies of women who are not tested during pregnancy and do not find out they are HIV-positive until they give birth. They say this is especially important in parts of Africa where women arrive to the labor room without knowledge of their HIV status, making it too late for other treatment options.
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
Breaking Medicine Technology: